White House Backs Down on Controversial Plan to Politicize NIH Grant Approval Process
The Trump Administration has abandoned a proposed executive order that would have created a new board requiring unanimous approval of all National Institutes of Health grants before funding distribution. Congressional opposition, including from Republican Senator Susan Collins and 30 Democratic colleagues, prompted the White House to withdraw the controversial plan intended to review research deemed politically objectionable. While the immediate threat has been averted, advocacy groups remain vigilant about potential future attempts to insert political review into federal research funding.
The proposed executive order would have fundamentally altered how the NIH distributes research funding by inserting a political review layer into the grants process. A newly created board including OMB Director Russell Vought and NIH Director Jay Bhattacharya would have required unanimous approval before any grants could be funded, effectively giving either member veto power over research projects. The administration had specifically targeted the NIH's extramural funding programs, expressing concern about research it characterized as ideologically driven.
Congressional opposition proved decisive in blocking the initiative. Republican Senator Susan Collins, whose committee controls appropriations, directly warned the OMB director against undermining the established peer review system. Her bipartisan coalition, including 30 Democratic senators, signaled that such politicization of federal research funding would face legislative resistance. The White House withdrew the plan within days of this coordinated pushback, though officials indicated the effort could resurface.
The episode illustrates ongoing tensions over federal research funding oversight. A politicized grants process could affect researchers' ability to pursue investigations deemed controversial and may influence which scientific questions receive federal support. Universities and research institutions dependent on NIH funding face uncertainty about future grantmaking standards. The broader regulatory effort to implement political review across federal agencies suggests this particular battle may be temporary, potentially affecting long-term research priorities and scientific independence across multiple sectors.